Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY: ASX )

10.49 -0.27 (-2.51%)
Official Closing Price Updated: 7:00 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,794,476
Open 10.60
Bid (Size) 10.30 (2)
Ask (Size) 10.49 (1)
Prev. Close 10.76
Today's Range 10.41 - 10.63
52wk Range 8.100 - 12.86
Shares Outstanding 4,408,018,732
Dividend Yield 3.07%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Current Report ASE Technology
Share price rose about 19% in the past year from $8.59 to $10.21, as of Friday’s market close. 
Via Talk Markets
Topics Stocks / Equities

Performance

YTD
+4.69%
+4.69%
1 Month
+4.80%
+4.80%
3 Month
+5.32%
+5.32%
6 Month
-11.85%
-11.85%
1 Year
+19.61%
+19.61%

More News

Read More
Baker Hughes Secures Liquefaction Equipment Order for Woodside Louisiana LNG
From Baker Hughes
Via GlobeNewswire
ASE’s Sustainability Efforts Receive International Recognition With a Ranking on the Dow Jones Sustainability Indices for the Ninth Year in a Row
From ASE Technology Holding Co., Ltd.
Via Business Wire
Earnings Outlook For ASE Tech Holding Co
Via Benzinga
Precious Metals & Critical Materials Virtual Investor Conference: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
American Rare Earths to Present at the Precious Metals & Critical Materials Virtual Investor Conference December 11th
From Virtual Investor Conferences
Via GlobeNewswire
Precious Metals & Critical Materials Virtual Investor Conference Agenda Announced for December 10th and 11th
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
From Virtual Investor Conferences
Via GlobeNewswire
Life360 Named One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500™
From Life360, Inc.
Via GlobeNewswire
Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Life360 Reports Record Q3 2024 Results
From Life360, Inc.
Via GlobeNewswire
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ISE Labs Investment Secures the Establishment of New Site for Semiconductor Packaging and Test in Mexico
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ASE “Guardians of the Sea” Wins Gold at the PwC Sustainability Impact Awards
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy
From Travere Therapeutics, Inc.
Via GlobeNewswire
Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer
From Cogstate Ltd.
Via GlobeNewswire
Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ATHA Energy Announces Option Agreements With Terra Uranium for Spire, Horizon, and Pasfield Projects
From ATHA Energy Corp.
Via GlobeNewswire
Majority Of Taiwanese Citizens Downplay Invasion Threat From China Within Next 5 Years: Here Is How TSMC, UMC And Others Would Be Impacted
Via Benzinga
Small Cap Growth Virtual Investor Conference Agenda Announced for October 10th
From Virtual Investor Conferences
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.